CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis

MLA

Ann D Bass, et al. “CLICK-MS and MASTER-2 Phase IV Trial Design: Cladribine Tablets in Suboptimally Controlled Relapsing Multiple Sclerosis.” Neurodegenerative Disease Management, vol. 11, Apr. 2021, pp. 99–111. EBSCOhost, https://doi.org/10.2217/nmt-2020-0059.

APA

Ann D Bass, Joshua Katz, Edward Fox, Derrick Robertson, Danielle E. Harlow, Jacob A. Sloane, Brooke Hayward, Augusto Miravalle, & Lori A Lebson. (2021). CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis. Neurodegenerative Disease Management, 11, 99–111. https://doi.org/10.2217/nmt-2020-0059

Chicago

Ann D Bass, Joshua Katz, Edward Fox, Derrick Robertson, Danielle E. Harlow, Jacob A. Sloane, Brooke Hayward, Augusto Miravalle, and Lori A Lebson. 2021. “CLICK-MS and MASTER-2 Phase IV Trial Design: Cladribine Tablets in Suboptimally Controlled Relapsing Multiple Sclerosis.” Neurodegenerative Disease Management 11 (April): 99–111. doi:10.2217/nmt-2020-0059.